SEC Form 4 · accession 0001209191-18-058330
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Collins Presnell
Officer — Chief Scientific Officer
Period of report
Nov 8, 2018
Accepted (ET)
Nov 13, 2018 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 8, 2018 | S | 40,000 | $1.27 | D | 292,193 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2This number does not include 2,257,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 2,549,385 shares of common stock.